DK1122307T3 - Human carnosinase 2 - Google Patents
Human carnosinase 2Info
- Publication number
- DK1122307T3 DK1122307T3 DK00400313T DK00400313T DK1122307T3 DK 1122307 T3 DK1122307 T3 DK 1122307T3 DK 00400313 T DK00400313 T DK 00400313T DK 00400313 T DK00400313 T DK 00400313T DK 1122307 T3 DK1122307 T3 DK 1122307T3
- Authority
- DK
- Denmark
- Prior art keywords
- carnosinase
- human
- polypeptides
- polynucleotides
- disclosed
- Prior art date
Links
- 102100031007 Cytosolic non-specific dipeptidase Human genes 0.000 title abstract 2
- 101000919690 Homo sapiens Cytosolic non-specific dipeptidase Proteins 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Microbiology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00400313A EP1122307B1 (en) | 2000-02-04 | 2000-02-04 | Human carnosinase 2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1122307T3 true DK1122307T3 (da) | 2009-08-17 |
Family
ID=8173533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00400313T DK1122307T3 (da) | 2000-02-04 | 2000-02-04 | Human carnosinase 2 |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1122307B1 (da) |
| AT (1) | ATE429489T1 (da) |
| DE (1) | DE60042056D1 (da) |
| DK (1) | DK1122307T3 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002020805A2 (en) * | 2000-09-11 | 2002-03-14 | Bayer Aktiengesellschaft | Regulation of human carboxypeptidase-like enzyme |
| DE10360956A1 (de) * | 2003-12-23 | 2005-07-28 | Ruprecht-Karls-Universität Heidelberg | System und Verfahren zum Nachweis von diabetischer Nephropatie oder einer Prädisposition dafür |
| WO2005064013A1 (en) * | 2003-12-23 | 2005-07-14 | Bart Janssen | The use of carnosine metabolism-associated genes to determine genetic predisposition/susceptibility to diabetic nephropathy |
| CN119570765B (zh) * | 2025-02-08 | 2025-05-16 | 上海昱菘生物科技有限公司 | 用于合成l-肌肽的氨肽酶及其应用 |
-
2000
- 2000-02-04 EP EP00400313A patent/EP1122307B1/en not_active Expired - Lifetime
- 2000-02-04 DE DE60042056T patent/DE60042056D1/de not_active Expired - Lifetime
- 2000-02-04 DK DK00400313T patent/DK1122307T3/da active
- 2000-02-04 AT AT00400313T patent/ATE429489T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE429489T1 (de) | 2009-05-15 |
| DE60042056D1 (de) | 2009-06-04 |
| EP1122307A1 (en) | 2001-08-08 |
| EP1122307B1 (en) | 2009-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1961767T3 (da) | Diagnose og behandling af cancere og andre lidelser | |
| WO1998031799A3 (en) | Polynucleotides and polypeptides encoding receptors | |
| IL153052A0 (en) | Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods | |
| EP1001023A3 (en) | Frizzled-4, a putative Wnt-receptor | |
| EP1621623A3 (en) | Basb029polynucleotide(s) and polypeptides from neisseria meningitis | |
| NO20000731D0 (no) | Neisseria-lactodweeinbindingsprotein | |
| DE60042056D1 (de) | Menschliche Carnosinase 2 | |
| EP0885959A3 (en) | Human Wnt-5b protein | |
| ATE373718T1 (de) | 17867, eine menschliche aminopeptidase | |
| EP0943684A3 (en) | Frizzled-like polypeptides and polynucleotides | |
| EP0887416A3 (en) | Human AFC1 | |
| WO2001083744A3 (en) | Natrium-calcium exchanger protein | |
| EP0887415A3 (en) | Human RCE1 | |
| WO2001043759A3 (en) | Use of 11cby popypeptides and polynuceotides | |
| DE69921649D1 (de) | Moraxella catarrhalis pilq proteine | |
| WO2001085921A3 (en) | Human serine-threonine kinase-4 | |
| WO2001068816A8 (en) | Human histamine h3 gene variant-3 | |
| DK1309690T3 (da) | MFQ-111, et humant GTPase-lignende protein | |
| EP0897009A3 (en) | HKABY60 polypeptides | |
| WO1998042833A3 (en) | Kv potassium channel polypeptides and polynucleotides | |
| WO2001043760A3 (en) | Use of ucp3 polynucleotides and polypeptides | |
| WO2002002780A3 (en) | Human serine-threonine kinase | |
| EP0949332A3 (en) | HSSCRG1 polypeptides | |
| EP0897986A3 (en) | Aspartic proteinase 5 (ASP5) | |
| WO2001077148A3 (en) | Human lipid binding protein 1 |